Stay updated on Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.5%

- Check21 days agoChange DetectedA government funding lapse notice has been added at the top of the page with operating-status guidance. The page revision has been updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedThe updates are minor UI/metadata changes (Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), along with corresponding deletions of older labels (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4 with no other content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section with Kentucky as a study site. Removed the Kentucky Locations entry and the HHS Vulnerability Disclosure link; revision updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0. This is a metadata update and does not alter the study details.SummaryDifference0.1%

Stay in the know with updates to Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.